EU research on rare diseases
In the EU, a rare disease is one that affects no more than 1 person in 2,000. This means that between 6,000 and 8,000 different rare diseases affect or will affect an estimated 30 million people in the EU.
The area of rare diseases has been long recognised as a field where EU and international collaboration is an indispensable condition to progress.
The EU has made major investments during the last two decades to support cross-border and interdisciplinary research for rare diseases. More than €1.4 billion has been made available from FP7 and Horizon 2020 to more than 200 collaborative research and innovation projects in the area of rare diseases.
Such collaborations allow researchers, clinicians, companies (including SMEs) and patient organisations to pool resources to increase the understanding of rare diseases, develop new diagnostics and therapies for patients, and promote best practices for used in hospitals and healthcare systems.
The launch in January 2019 of the European Joint Programme on Rare Diseases (EJP RD) marked an important milestone in Europe. The EJP RD is creating a comprehensive, sustainable ecosystem allowing a virtuous circle between research, care and medical innovation.
The project pools together resources at national and European level, at a scale never achieved before. It gathers research funders, universities, research organisations and infrastructures, hospitals and patient organisations from 35 countries, including 26 out of 27 EU countries. The EU contributes €55 million out of a total investment of over €100 million.
Collaboration and jobs
Look for project partners and view profiles of all organisations that have received funding via the funding and tender opportunities portal.
Supports annual joint transnational calls for proposal for rare diseases research projects.
Co-fund supports joint calls for rare diseases with the aime of better aligning national funding programmes.
supports projects accelerating the research and development process for drugs for rare diseases.
Consortium of 50 members from five continents including the Commission which aims to ensure 200 new therapies and means to diagnose should be available by 2020.
Researcher jobs in related fields
Projects and results
Projects in the area of rare diseases on the Commission's primary portal for results of EU-funded research projects.
Stories of particularly successful EU-funded research projects.
Platform where framework programme funding recipients present their results to search, contact their owners and form partnerships.
Database that provides information on the nature of health projects and their results. Managed by the Commission's Consumers, Health, Agriculture and Food Executive Agency.
Scientific publications, tools and databases
Interactive reporting platform, composed of a set of sheets that allows series of views to discover and filter Horizon 2020 data.
Scientific publications produced by the European Commission (JRC)
Single point of access to open data produced by the EU institutions. All data free to use for commercial and non-commercial purposes.
You can access all scientific publications from Horizon 2020 via OpenAIRE.